Therapy-related B-lymphoblastic leukemia after multiple myeloma

New therapies for multiple myeloma have improved outcomes, but are associated with therapy-related hematologic malignancies. We report eight patients with therapy-related B-lymphoblastic leukemias (t-B-ALL) in the setting of therapy for multiple myeloma, which included lenalidomide maintenance. A su...

Descripción completa

Detalles Bibliográficos
Autores principales: Kallen, Michael E., Koka, Rima, Singh, Zeba N., Ning, Yi, Kocoglu, Mehmet H., Badros, Ashraf Z., Niyongere, Sandrine, Duong, Vu H., Emadi, Ashkan, Baer, Maria R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637917/
https://www.ncbi.nlm.nih.gov/pubmed/36353199
http://dx.doi.org/10.1016/j.lrr.2022.100358

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637917/
https://www.ncbi.nlm.nih.gov/pubmed/36353199
http://dx.doi.org/10.1016/j.lrr.2022.100358

Ejemplares similares